These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15823567)

  • 21. Altered arginine metabolism in the central nervous system (CNS) of the Cln3-/- mouse model of juvenile Batten disease.
    Chan CH; Ramirez-Montealegre D; Pearce DA
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):189-207. PubMed ID: 19284480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CLN3 regulates endosomal function by modulating Rab7A-effector interactions.
    Yasa S; Modica G; Sauvageau E; Kaleem A; Hermey G; Lefrancois S
    J Cell Sci; 2020 Mar; 133(6):. PubMed ID: 32034082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A human model of Batten disease shows role of CLN3 in phagocytosis at the photoreceptor-RPE interface.
    Tang C; Han J; Dalvi S; Manian K; Winschel L; Volland S; Soto CA; Galloway CA; Spencer W; Roll M; Milliner C; Bonilha VL; Johnson TB; Latchney L; Weimer JM; Augustine EF; Mink JW; Gullapalli VK; Chung M; Williams DS; Singh R
    Commun Biol; 2021 Feb; 4(1):161. PubMed ID: 33547385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).
    Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM
    Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cln3-mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and Ppt1-enzyme activity in the lysosome.
    Appu AP; Bagh MB; Sadhukhan T; Mondal A; Casey S; Mukherjee AB
    J Inherit Metab Dis; 2019 Sep; 42(5):944-954. PubMed ID: 31025705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-dependent therapeutic effect of memantine in a mouse model of juvenile Batten disease.
    Kovács AD; Saje A; Wong A; Ramji S; Cooper JD; Pearce DA
    Neuropharmacology; 2012 Oct; 63(5):769-75. PubMed ID: 22683643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of specificity of antibodies raised against CLN3, the lysosomal/endosomal transmembrane protein mutated in juvenile Batten disease.
    Nelson T; Pearce DA; Kovács AD
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29089465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the Lysosomal Membrane Protein, CLN3, in the Regulation of Cathepsin D Activity.
    Cárcel-Trullols J; Kovács AD; Pearce DA
    J Cell Biochem; 2017 Nov; 118(11):3883-3890. PubMed ID: 28390177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease.
    Järvelä I; Sainio M; Rantamäki T; Olkkonen VM; Carpén O; Peltonen L; Jalanko A
    Hum Mol Genet; 1998 Jan; 7(1):85-90. PubMed ID: 9384607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulating membrane fluidity corrects Batten disease phenotypes in vitro and in vivo.
    Schultz ML; Tecedor L; Lysenko E; Ramachandran S; Stein CS; Davidson BL
    Neurobiol Dis; 2018 Jul; 115():182-193. PubMed ID: 29660499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Btn2, a Hook1 ortholog and potential Batten disease-related protein, mediates late endosome-Golgi protein sorting in yeast.
    Kama R; Robinson M; Gerst JE
    Mol Cell Biol; 2007 Jan; 27(2):605-21. PubMed ID: 17101785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).
    Bosch ME; Aldrich A; Fallet R; Odvody J; Burkovetskaya M; Schuberth K; Fitzgerald JA; Foust KD; Kielian T
    J Neurosci; 2016 Sep; 36(37):9669-82. PubMed ID: 27629717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms of the juvenile form of Batten disease: important role of MAPK signaling pathways (ERK1/ERK2, JNK and p38) in pathogenesis of the malady.
    Shematorova EK; Shpakovski DG; Chernysheva AD; Shpakovski GV
    Biol Direct; 2018 Sep; 13(1):19. PubMed ID: 30621751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osmoregulation of ceroid neuronal lipofuscinosis type 3 in the renal medulla.
    Stein CS; Yancey PH; Martins I; Sigmund RD; Stokes JB; Davidson BL
    Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1388-400. PubMed ID: 20219947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel c.1135_1138delCTGT mutation in CLN3 leads to juvenile neuronal ceroid lipofuscinosis.
    Drack AV; Miller JN; Pearce DA
    J Child Neurol; 2013 Sep; 28(9):1112-6. PubMed ID: 23877479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Batten disease (JNCL) is linked to disturbances in mitochondrial, cytoskeletal, and synaptic compartments.
    Luiro K; Kopra O; Blom T; Gentile M; Mitchison HM; Hovatta I; Törnquist K; Jalanko A
    J Neurosci Res; 2006 Oct; 84(5):1124-38. PubMed ID: 16941499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease.
    Centa JL; Jodelka FM; Hinrich AJ; Johnson TB; Ochaba J; Jackson M; Duelli DM; Weimer JM; Rigo F; Hastings ML
    Nat Med; 2020 Sep; 26(9):1444-1451. PubMed ID: 32719489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel role of the Batten disease gene CLN3: association with BMP synthesis.
    Hobert JA; Dawson G
    Biochem Biophys Res Commun; 2007 Jun; 358(1):111-6. PubMed ID: 17482562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of Cln3 function in the social amoeba Dictyostelium discoideum causes pleiotropic effects that are rescued by human CLN3.
    Huber RJ; Myre MA; Cotman SL
    PLoS One; 2014; 9(10):e110544. PubMed ID: 25330233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A knock-in reporter mouse model for Batten disease reveals predominant expression of Cln3 in visual, limbic and subcortical motor structures.
    Ding SL; Tecedor L; Stein CS; Davidson BL
    Neurobiol Dis; 2011 Feb; 41(2):237-48. PubMed ID: 20875858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.